Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: A retrospective hospital register-based cohort study

BMJ Open

Volumn 1, Issue 2, 2011, Pages

  Yone, Eric Walter Pefura ^a,b   Kengne, André Pascal ^c   Kuaban, Christopher ^a,b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Yaounde Jamot Hospital   (Cameroon)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855474806     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000289     Document Type: Article

References (26)

1. WHO. Tuberculosis Profile, Cameroon. https://extranet.who.int/sree/ Reports (accessed 26 Jun 2011).
2. Aït-Khaled N, Alarcón E, Armengol R, et al. Prise en charge de la tuberculose. guide des é léments essentiels pour une bonne pratique. Sixième édn. Paris: Union Internationale Contre la Tuberculose et les Maladies Respiratorires, 2010:P64.
3. Programme National de Lutte contre la Tuberculose. Guide Technique pour le personnel de santé. 2ème édn révisée. Yaoundé : Ministère de la Santé Publique du Cameroun, 2004:P40.
4. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007;370:2030-43. (Pubitemid 350236315)
5. Organisation Mondiale de la Santé. Le traitement de la tuberculose: Principes à l'intention des programmes nationaux. Troisième édn. Genève: OMS, 2003:14-76.
6. Kuaban C, Bame R, Mouangue L, et al. Non conversion of sputum smear positive in new smear positive pulmonary tuberculous patients in Yaounde, Cameroon. East Afr Med J 2009;86:219-25.
7. Castelnuovo B. A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci 2010;10:320-4.
8. Elbireer S, Guwatudde D, Mudiope P, et al. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Trop Med Int Health. Published Online First: 18 May 2011. doi:10.1111/ j.1365-3156.2011.02800.x.
9. Kandel TR, Mfenyana K, Chandia J, et al. The prevalence of and reasons for interruption of anti-tuberculosis treatment by patients at Mbekweni Health Centre in the King Sabata Dalindyebo (KSD) District in the Eastern Cape province. SA Fam Pract 2008;50:47.
10. Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998;2:372-7. (Pubitemid 28239858)
11. Shargie EB, Lindtjorn B. Determinants of treatment adherence among smear-positive tuberculosis patients in Southern Ethiopia. PLOS medicine 2007;4:280-7.
12. Kaona AD, Tuba M, Siziya S, et al. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 2004;4:68.
13. Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis 2002;6:573-9. (Pubitemid 36898181)
14. Kuaban C, Mbuntum F. Treatment outcome and risk factors for default in adult with pulmonary tuberculosis in Yaounde, Cameroon. Health Sci Dis 2002;1:5-9.
15. Resolution WHA44.8. Tuberculosis control programme. In: Handbook of resolutions and decisions of the World Health Assembly and the Executive Board. Geneva: World Health Organization, 1993:116 (WHA44/1991/REC/1).
16. International Union Against Tuberculosis and Lung Disease. Best Practice for the Care of Patients with Tuberculosis. Paris: USAID, 2007:P51.
17. Kruk ME, Schwalbe NR, Aguiar CA. Timing of default from tuberculosis treatment: a systematic review. Trop Med Int Health 2008;13:703-12. (Pubitemid 351561604)
18. Caylà JA, Rodrigo T, Ruiz-Manzano J, et al; Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE). Tuberculosis treatment adherence and fatality in Spain. Respir Res 2009;10:121.
19. UNAIDS. "HIV and AIDS-related Stigmatisation, Discrimination and Denial: Forms, Contexts and Determinants," Research Studies from Uganda and India (prepared for UNAIDS by Peter Aggleton). Geneva:UNAIDS, 2000:1-28.
20. USAID. Breaking the Cycle: Stigma, Discrimination, Internal stigma, and HIV. POLICY project (prepared for USAID by Ken Morrison). Washington, DC: USAID, 2006:1-17.
21. Bam TS, Gunneberg C, Chamroonsawasdi K, et al. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis 2006;10:270-6.
22. Chang KC, Leung CC, Tam CM. Risk factors for defaulting from antituberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004;8:1492-98.
23. Gelmanova IY, Keshavjee S, Golubchikova VT, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007;85:703-11. (Pubitemid 47416722)
24. Castelnuovo B, Hermans S, Park R, et al. Evaluation of the Impact of TB-HIV Integrated Care in Reducing the Proportion of Patients Defaulting Anti TB Treatment in a Large Urban HIV Clinic in Kampala, Uganda [abstract]. IAS, 2011.
25. Dalal RP, Macphail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008;47:101-7. (Pubitemid 351619376)
26. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resourcelimited settings: systematic review and meta-analysis. PLoS One 2009;4:e5790.